FASL Antikörper
-
- Target Alle FASL Antikörper anzeigen
- FASL (Fas Ligand (TNF Superfamily, Member 6) (FASL))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser FASL Antikörper ist unkonjugiert
-
Applikation
- Flow Cytometry (FACS), ELISA, Immunoprecipitation (IP)
- Produktmerkmale
- Purified IgG
- Aufreinigung
- Purified
- Klon
- 14C2
- Isotyp
- IgG1
- Top Product
- Discover our top product FASL Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1.0 mg/mL
-
-
Human heat shock protein-specific cytotoxic T lymphocytes display potent antitumour immunity in multiple myeloma." in: British journal of haematology, Vol. 166, Issue 5, pp. 690-701, (2014) (PubMed).
: "Natural killer cells in allergic rhinitis patients and nonatopic controls." in: International archives of allergy and immunology, Vol. 153, Issue 3, pp. 234-8, (2010) (PubMed).
: "Amplification of Fas-mediated apoptosis in type II cells via microdomain recruitment." in: Molecular and cellular biology, Vol. 25, Issue 15, pp. 6811-20, (2005) (PubMed).
: "
-
Human heat shock protein-specific cytotoxic T lymphocytes display potent antitumour immunity in multiple myeloma." in: British journal of haematology, Vol. 166, Issue 5, pp. 690-701, (2014) (PubMed).
-
- Target
- FASL (Fas Ligand (TNF Superfamily, Member 6) (FASL))
- Andere Bezeichnung
- CD178 (FASL Produkte)
- Hintergrund
- Synonyms: FAS LIGAND
- Gen-ID
- 356
- UniProt
- P48023
- Pathways
- Apoptose, EGFR Signaling Pathway, Production of Molecular Mediator of Immune Response, Positive Regulation of Endopeptidase Activity
-